Trademark Overview
On Friday, April 28, 2023, a trademark application was filed for ROSLINCT with the United States Patent and Trademark Office. The USPTO has given the ROSLINCT trademark a serial number of 97913008. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 9, 2024. This trademark is owned by Roslin Cell Therapies Limited. The ROSLINCT trademark is filed in the Treatment & Processing of Materials Services, Computer & Software Products & Electrical & Scientific Products, Paper & Printed Material Products, Advertising, Business and Retail Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Education and training services, namely, classes, seminars, tutorials, conferences and workshops in the fields of cell therapy and gene therapy; provision of online education, training and teaching services, namely, classes, non-downloadable webinars and tutorials in the fields of cell therapy and gene therapy; arranging, organising and conducting of colloquiums, conferences, congresses, seminars and symposiums in the fields of cell therapy and gene therapy; publication of books, scientific papers and texts in the fields of cell therapy and gene therapy; information, advisory and consultancy services related to the aforesaid
Contract manufacturing of pharmaceutical and biopharmaceutical products in the fields of cell therapy and gene therapy; contract manufacturing in the fields of cell therapy and gene therapy; custom manufacturing of pharmaceutical and biopharmaceutical products in the fields of cell therapy and gene therapy; custom manufacturing in the fields of cell therapy and gene therapy; custom fabrication and production of cells for others; manufacturing process consulting in the fields of cell therapy and gene therapy; information, advisory and consultancy services related to the aforesaid
Scientific apparatus and instruments, namely, bioreactors for cell culturing, laboratory incubators and laboratory centrifuges for use in the development, testing, training and, manufacturing of stem cells and related cell and gene therapy products; downloadable computer software and hardware for use in the development, testing, training and, manufacturing of stem cells and related cell and gene therapy products; replacement and structural parts and fittings for the aforesaid goods
Paper signs, cardboard signs, and printed matter, namely, brochures, books and journals in the fields of cell therapy and gene therapy; paper instructional and teaching material, except apparatus, in the fields of cell therapy and gene therapy
Business information, consultancy and management services in the fields of designing, building, testing and validating processes and systems for use in cell therapy and gene therapy services; business consultation services in the nature of technology transfer advice and management in the fields of cell therapy and gene therapy; advertising, marketing and promotional services in the fields of cell therapy and gene therapy; information, advisory and consultancy services related to the aforesaid
Medical services relating to the removal, treatment and processing of stem cells; medical services, namely, stem cell therapy services; medical services, namely, gene therapy services; stem cell bank services, namely, stem cell storage; information, advisory and consultancy services related to the aforesaid
Scientific research, development and testing services in the fields of cell therapy and gene therapy; research and development of new products for others in the fields of cell therapy and gene therapy; pharmaceutical and biopharmaceutical research and development services in the fields of cell therapy and gene therapy; scientific consultancy services in the fields of designing, building, testing and validating processes and systems for use in cell therapy and gene therapy services; design and development of computer hardware and software in the biopharmaceutical, cell therapy and gene therapy fields; development of computer databases in the biopharmaceutical, cell therapy and gene therapy fields; scientific development of custom assays for cell therapy and gene therapy; stem cell research services; information, advisory and consultancy services related to the aforesaid
